OssDsign Stock
OssDsign Stock price
Key metrics
Is OssDsign a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
Financial data from OssDsign
| Mar '25 |
+/-
%
|
||
| Revenue | 151 151 |
9%
9%
|
|
| Gross Profit | 145 145 |
33%
33%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -50 -50 |
64%
64%
|
| Net Profit | -53 -53 |
63%
63%
|
|
In millions SEK.
Don't miss a Thing! We will send you all news about OssDsign directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
OssDsign AB is a holding company, which engages in the development and sales of medical technology products. The company is headquartered in Uppsala, Uppsala and currently employs 27 full-time employees. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
| Head office | Sweden |
| CEO | Mr. Lundqvist |
| Employees | 31 |
| Website | www.ossdsign.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
